[1] Yang XR, Quam MBM, Zhang TC, Sang SW. Global burden for dengue and the evolving pattern in the past 30 years. J Travel Med 2021;28(8):taab146. https://doi.org/10.1093/jtm/taab146.
[2] Wilder-Smith A, Ooi EE, Horstick O, Wills B. Dengue. Lancet 2019;393(10169):350 − 63. https://doi.org/10.1016/S0140-6736(18)32560-1.
[3] WHO. Global dengue surveillance. [2026-01-30]. https://worldhealthorg.shinyapps.io/dengue_global/.
[4] Tsheten T, Gray DJ, Clements ACA, Wangdi K. Epidemiology and challenges of dengue surveillance in the WHO South-East Asia Region. Trans R Soc Trop Med Hyg 2021;115(6):583 − 99. https://doi.org/10.1093/trstmh/traa158.
[5] Lai SJ, Johansson MA, Yin WW, Wardrop NA, Van Panhuis WG, Wesolowski A, et al. Seasonal and interannual risks of dengue introduction from South-East Asia into China, 2005-2015. PLoS Negl Trop Dis 2018;12(11):e0006743. https://doi.org/10.1371/journal.pntd.0006743.
[6] Lun X, Wang YG, Zhao CC, Wu HX, Zhu CY, Ma DL, et al. Epidemiological characteristics and temporal-spatial analysis of overseas imported dengue fever cases in outbreak provinces of China, 2005–2019. Infect Dis Poverty 2022;11(1):12. https://doi.org/10.1186/s40249-022-00937-5.
[7] Zhai HR, Qin HJ, Chen JY, Ren Q, Mu D, Chen QL, et al. Changing epidemiologic characteristics of dengue fever in Chinese mainland between 2019 and 2024. Zoonoses 2025;5(1):961. https://doi.org/10.15212/zoonoses-2024-0069.
[8] Yue YJ, Liu QY, Liu XB, Wu HX, Xu MF. Comparative analyses on epidemiological characteristics of dengue fever in Guangdong and Yunnan, China, 2004-2018. BMC Public Health 2021;21(1):1389. https://doi.org/10.1186/s12889-021-11323-5.
[9] Deng SZ, Liu XY, Su JJ, Xiang LH, Chang LT, Zhu JJ, et al. Epidemiological and cluster characteristics of dengue fever in Yunnan Province, Southwestern China, 2013-2023. BMC Infect Dis 2025;25(1):95. https://doi.org/10.1186/s12879-024-10403-2.
[10] Yue YJ, Liu XB, Ren DS, Wu HX, Liu QY. Spatial dynamics of dengue fever in mainland China, 2019. Int J Environ Res Public Health 2021;18(6):2855. https://doi.org/10.3390/ijerph18062855.
[11] Ni HB, Cai XY, Ren JR, Dai TT, Zhou JY, Lin JM, et al. Epidemiological characteristics and transmission dynamics of dengue fever in China. Nat Commun 2024;15(1):8060. https://doi.org/10.1038/s41467-024-52460-w.
[12] National Health and Family Planning Commission of the People’s Republic of China. WS 216-2018 Diagnosis for dengue fever. Beijing: China Standards Press, 2018. http://www.csres.com/detail/312267.html. (In Chinese).
[13] National Disease Control and Prevention Administration. Technical Guidelines for Dengue Fever Prevention and Control (2025 Edition) [J]. Chinese Journal of Virology 2025, 15(05): 417-425.(In Chinese).
[14] Yue YJ, Liu XB, Ren DS, Yin WW. Epidemiological characteristics of dengue fever in Chinese Mainland, 2005-2020. Chin J Vector Biol Control 2023;34(6):761 − 6,818. https://doi.org/10.11853/j.issn.1003.8280.2023.06.010.
[15] Wu Q, Dong SW, Li XK, Yi BY, Hu H, Guo ZM, et al. Effects of COVID-19 non-pharmacological interventions on dengue infection: a systematic review and meta-analysis. Front Cell Infect Microbiol 2022;12:892508. https://doi.org/10.3389/fcimb.2022.892508.
[16] World Health Organization. Report on the global arbovirus surveillance and response capacity survey 2021-2022. [2026-01-30]. https://www.who.int/ publications/b/77071.